TrkA antagonists (Proximagen)

N/A

Report date: 2025/03/20 09:35:59
NME

Base Information

Drug NameTrkA antagonists (Proximagen)
Drug Alias NameTrkA program (Biovitrum)TrkA program (Proximagen)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNerve growth factor receptor Trk-A antagonists
TargetsNerve growth factor receptor Trk-A
Therapy Area/IndicationsPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwedenUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSwedish Orphan Biovitrum Ab (Publ)
China Registration ClassN/A

Develop Information

Active CompaniesProximagen Group plc
Inactive CompaniesSwedish Orphan Biovitrum Ab (Publ)
Active IndicationsPain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A